News Release

Announcing Human Longevity as Tier 3 Sponsor of ARDD 2024

Empowering the future of aging research: Human Longevity to sponsor ARDD 2024, the world's largest conference on aging research in the biopharmaceutical industry

Meeting Announcement

Aging Research and Drug Discovery

Announcing Human Longevity as Tier 3 Sponsor of ARDD 2024


Empowering the future of aging research: Human Longevity to sponsor ARDD 2024, the world's largest conference on aging research in the biopharmaceutical industry

view more 

Credit: Aging Research and Drug Discovery

The University of Copenhagen is excited to announce Human Longevity as a Tier 3 Sponsor of the 11th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 26 - August 30, 2024 on-site at the Ceremonial Hall, University of Copenhagen, and online.

Built by the pioneers of the human genome sequencing effort since 2013, Human Longevity is the global leader in advancing the Human Longevity Care movement, on a mission to discover and harness the technological and biological interventions that amplify span of life, health, & high-performance. Human Longevity, Inc. is committed to accelerating living to 100+ by revolutionizing the landscape of the current system of "sickcare" to true "healthcare". By continually adding and analyzing our client's health data, they are transforming treatment from a reactive practice to one that is proactive, preventative, and personalized.

ARDD 2024 is set to feature a stellar lineup. Human Longevity, along with esteemed academic institutions, clinicians, industry leaders, investors, and pharmaceutical companies, will contribute to rich dialogues and present new research in the field of aging. This year, ARDD is proud to be a partner of XPRIZE Healthspan, a 7-year, $101 million global competition to revolutionize the way we approach human aging. Highlighting this collaboration, XPRIZE Healthspan will host its first XPRIZE Healthspan Team Summit at the 11th ARDD. The event underscores a shared commitment between ARDD and XPRIZE to fostering advancements in health and longevity, signaling an important milestone in efforts to enable everyone to live healthier and longer lives through extended healthspan.

“I’m extremely excited about this year's ARDD. We have a stellar academic lineup and an incredibly strong presence from leading companies in the aging field. This year the presence of pharma companies including Lilly, Lundbeck, Novartis, Regeneron and many others have been strengthened and we are super excited that XPRIZE will host their XPRIZE Healthspan Team Summit at ARDD. We are continuing to offer 3 travel grants for young scholars to attend ARDD and give generous poster awards for the top poster presentations. This edition of ARDD is shaping up to be a fantastic conference. Tickets are limited so we encourage everyone to sign up early to secure a spot in Copenhagen. I very much look forward to seeing old and new friends here in Copenhagen.” said Morten Scheibye-Knudsen, MD, Ph.D., University of Copenhagen.

“I'm genuinely thrilled about the upcoming ARDD conference this year! Building on the incredible success and full bookings of last year's event, this year promises again unique opportunities to connect with brilliant minds, fostering collaboration and showcasing groundbreaking research. What makes this year even more special is that we are eagerly welcoming even more pharmaceutical companies to join us on this journey. But that's not all – we're proud to announce our collaboration with XPRIZE. So, mark your calendar and join us at ARDD2024.” said Daniela Bakula, Ph.D., University of Copenhagen.

“Thanks to the tireless and disciplined efforts of the University of Copenhagen and specifically professors Scheibye-Knudsen and Bakula, the ARDD has grown to become the largest and most important conference in longevity biotechnology sponsored by over 30 biotechnology startups. The knowledge partner is BCG and executives of top pharma companies and editors of major journals are taking part. Unsurprisingly, the XPRIZE Healthspan, one of the most important initiatives in this industry, decided to host its first Team Summit during the ARDD. Copenhagen has become the epicenter of the global longevity community”, said Alex Zhavoronkov, Ph.D., founder and CEO of Insilico Medicine. 

Since 2020, ARDD has been opening with a clinically-oriented Longevity Medicine Day, which has been of great success in terms of attracting physicians and related health care professionals. “The upcoming 5th Longevity Medicine and XPRIZE Healthspan Team Summit at ARDD, marks a significant milestone in the integration of cutting-edge geroscience and AI into clinical practice, with a focus on extending healthspan and reversing biological aging. This collaboration underscores the essential role of physicians and healthcare professionals in translating scientific advancements into tangible medical solutions. As we gather the medical community for this event, we reaffirm our commitment to pushing the boundaries of longevity medicine to improve patient care and outcomes.” said Prof.Dr.Evelyne Bischof, the organizer of the Longevity Medicine Days.


For further information, images or interviews, please contact:


About Aging Research and Drug Discovery Conference

At ARDD, leaders in the aging, longevity, and drug discovery field will describe the latest progress in the molecular, cellular and organismal basis of aging and the search for interventions. Furthermore, the meeting will include opinion leaders in AI to discuss the latest advances of this technology in the biopharmaceutical sector and how this can be applied to interventions. Notably, this year we will have a special day called Longevity Medicine Day, specifically for physicians where the leading-edge knowledge of clinical interventions for healthy longevity will be described. ARRD intends to bridge clinical, academic and commercial research and foster collaborations that will result in practical solutions to one of humanity's most challenging problems: aging. Our quest to extend the healthy lifespan of everyone on the planet.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.